0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2005;165(21):2449. doi:10.1001/archinte.165.21.2449.
Text Size: A A A
Published online

C-REACTIVE PROTEIN AND RISK OF CARDIOVASCULAR DISEASE IN MEN AND WOMEN FROM THE FRAMINGHAM HEART STUDY

This article describes the experience of the Framingham Heart Study in the prediction of cardiovascular disease with C-reactive protein measurements and 8 years of follow-up. The study included 4446 adults free of cardiovascular disease at baseline; 283 developed major cardiovascular disease events. Categories of C-reactive protein were predictive of developing an event in age- and sex-adjusted models, but the effects were attenuated greatly in multivariable models.

See Article

DEPRESSION AND MEDICATION ADHERENCE IN OUTPATIENTS WITH CORONARY HEART DISEASE

In this article, Gehi and colleagues examined the association between current major depression and self-reported medication adherence in 940 outpatients with coronary heart disease. Among the 204 participants with major depression, 14% reported not taking their medications as prescribed compared with 5% of nondepressed participants (odds ratio, 2.8; 95% confidence interval, 1.7-4.7; P<.001), and this relation persisted after adjustment for potential confounding variables. Greater depressive symptom severity was associated with greater nonadherence. These results raise the possibility that medication nonadherence may contribute to adverse cardiovascular outcomes in depressed patients.

See Article

SUBCLINICAL HYPOTHYROIDISM AND THE RISK OF HEART FAILURE, OTHER CARDIOVASCULAR EVENTS, AND DEATH

Data on the risks of subclinical hypothyroidism are limited. Rodondi and colleagues examined the risks of heart failure, coronary heart disease, stroke, peripheral arterial disease, and death in relationship to thyrotropin (TSH) levels in a prospective cohort of 2730 older adults. Compared with euthyroid participants, older adults with a TSH level of 7.0 mIU/L or greater had a 2- to 3-fold increased risk of congestive heart failure events. Both incident and recurrent heart failure events were increased in this group. Heart failure events were not increased among those with TSH levels between 4.5 and 6.9 mIU/L. Subclinical hypothyroidism was not associated with increased risk for coronary heart disease, stroke, peripheral arterial disease, or cardiovascular or total mortality.

See Article

ALLERGIC RHINITIS, ASTHMA, AND ATHEROSCLEROSIS IN THE BRUNECK AND ARMY STUDIES

In this article, Knoflach and colleagues demonstrated that subjects with common allergic diseases (allergic rhinitis and asthma) are at an increased risk of atherosclerosis. This finding was consistently obtained in 2 independent population samples, one consisting of male youngsters (aged 17 or 18 years) (Atherosclerosis Risk Factors in Male Youngsters [ARMY] Study) and the other of middle-aged and elderly men and women (aged 40 to 70 years) (Bruneck Study). The results of Knoflach and colleagues fit very well into the emerging concept that key components of allergies such as leukotrienes or mast cells are active players in human atherogenesis and further extend the list of chronic inflammatory and immune-mediated diseases that has been linked to an enhanced burden of atherosclerosis.

See Article

QUALITY OF CARE AND OUTCOMES OF OLDER PATIENTS WITH HEART FAILURE HOSPITALIZED IN THE UNITED STATES AND CANADA

This study compared the process of care and outcomes of patients with heart failure in the United States and Canada. Among 28 521 US Medicare beneficiaries and 8180 Canadian patients who were hospitalized with heart failure, Ko et al found that more US patients underwent left ventricular ejection fraction assessment during hospitalization (61.2% vs 41.7%; P<.001). However, the use of β-blockers and angiotensin-converting enzyme inhibitors was not significantly different among those with documented left ventricular systolic dysfunction. The 30-day risk-standardized mortality was significantly lower for the US patients (8.9% vs 10.7%; P<.001), but 1-year risk-standardized mortality was not significantly different (32.2% vs 32.3%; P = .98).

Place holder to copy figure label and caption

Mortality rates at 30 days in the United States and Canada stratified by heart failure risk scores.

Graphic Jump Location

See Article

Figures

Place holder to copy figure label and caption

Mortality rates at 30 days in the United States and Canada stratified by heart failure risk scores.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.